Skip to content

Triple point of care testing for HIV, Syphilis and Hepatitis B virus versus Conventional Antenatal Screening A Comparative Study.

Triple point of care testing for HIV, Syphilis and Hepatitis B virus versus Conventional Antenatal Screening A Comparative Study.

Status
Active, not recruiting
Phases
Phase 4
Study type
Interventional
Source
PACTR
Registry ID
PACTR202409641377968
Enrollment
170
Registered
2024-09-19
Start date
2023-11-01
Completion date
Unknown
Last updated
2026-09-14

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Comparing Triple point of care antenatal screening with Coventional antenatal screening method

Interventions

Triple point of care testing for HIV Hepatitis B and Syphilis
Conventional antenatal screening

Sponsors

Seff
Lead Sponsor

Eligibility

Sex/Gender
Female

Inclusion criteria

Inclusion criteria: Pregnant women aged 18 years or older. Pregnant women with unknown or poor documentation of testing results for the triple infection were deemed eligible and were thus recruited into the study.

Exclusion criteria

Exclusion criteria: Pregnant women with mental health disorders. Pregnant women who had already been screened in the index pregnancy for the triple infection with properly documented evidence in our facility. Pregnant women at a gestational age greater than 36weeks

Design outcomes

Primary

MeasureTime frame
proportion of participants successfully screened over the total number of consenting participants in a strategy

Secondary

MeasureTime frame
1.Uptake which was defined as the increase in the number of women screened for triple infections over and above screening rates for any triple infection documented at baseline 2.Preference for the strategy; Defined as whether participants preferred POCTs over conventional laboratory tests 3.Preference for turnaround time (TAT); is the time to complete the tests and receive results,4.The impact defined by the number of infections detected/confirmed relative to the total number of participants screened,

Countries

Nigeria

Contacts

Public ContactNneoma Nnaemeka

Laboratory Scientist

anointin1675@gmail.com+2348063953869

Outcome results

None listed

Source: PACTR (via WHO ICTRP) · Data processed: Sep 19, 2026